These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 12361897

  • 1. The percentage of free prostatic-specific antigen is also useful in men with normal digital rectal examination and serum prostatic-specific antigen between 10.1 and 20 ng/ml.
    Morote J, Trilla E, Esquena S, Serrallach F, Abascal JM, Muñoz A, Id M'Hammed Y, de Torres IM.
    Eur Urol; 2002 Oct; 42(4):333-7. PubMed ID: 12361897
    [Abstract] [Full Text] [Related]

  • 2. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml.
    Martínez-Piñeiro L, Tabernero A, Contreras T, Madero R, Lozano D, López-Tello J, Alonso-Dorrego JM, Picazo ML, González Gancedo P, Martínez-Piñeiro JA, de La Peña JJ.
    Eur Urol; 2000 Mar; 37(3):289-96. PubMed ID: 10720854
    [Abstract] [Full Text] [Related]

  • 3. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG, Pinover WH, Horwitz EM, Parlanti A, Mazzoni S, Raysor S, Mirchandani I, Greenberg RE, Pollack A, Hanks GE, Watkins-Bruner D.
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [Abstract] [Full Text] [Related]

  • 4. Clinical usefulness of free PSA in early detection of prostate cancer.
    Luboldt HJ, Swoboda A, Börgermann C, Fornara P, Rübben H, Early Detection Project Group of the German Society of Urology.
    Onkologie; 2001 Feb; 24(1):33-7. PubMed ID: 11441278
    [Abstract] [Full Text] [Related]

  • 5. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B, Zlotta AR, Byttebier G, Shariat S, Omar M, Schulman CC, Marberger M.
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.
    Törnblom M, Norming U, Adolfsson J, Becker C, Abrahamsson PA, Lilja H, Gustafsson O.
    Urology; 1999 May; 53(5):945-50. PubMed ID: 10223488
    [Abstract] [Full Text] [Related]

  • 7. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M.
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of percent free prostate-specific antigen density to improve the specificity for detecting prostate cancer in patients with normal rectal examinations and intermediate prostate-specific antigen levels.
    Baltaci S, Aksoy H, Türkölmez K, Elhan AH, Ozden E, Göğüş O.
    Urol Int; 2003 Apr; 70(1):36-41. PubMed ID: 12566813
    [Abstract] [Full Text] [Related]

  • 10. Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma.
    Bazinet M, Meshref AW, Trudel C, Aronson S, Péloquin F, Nachabe M, Bégin LR, Elhilali MM.
    Urology; 1994 Jan; 43(1):44-51; discussion 51-2. PubMed ID: 7506853
    [Abstract] [Full Text] [Related]

  • 11. Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10-20 ng/mL and normal digital rectal examination.
    Chiu PK, Teoh JY, Lee WM, Yee CH, Chan ES, Hou SM, Ng CF.
    Investig Clin Urol; 2016 Sep; 57(5):336-42. PubMed ID: 27617315
    [Abstract] [Full Text] [Related]

  • 12. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, Juusela H, Määttänen L, Auvinen A.
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [Abstract] [Full Text] [Related]

  • 13. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.
    Catalona WJ, Richie JP, deKernion JB, Ahmann FR, Ratliff TL, Dalkin BL, Kavoussi LR, MacFarlane MT, Southwick PC.
    J Urol; 1994 Dec; 152(6 Pt 1):2031-6. PubMed ID: 7525994
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Early diagnosis of prostate cancer in the Western Cape.
    Heyns CF, Naudé AM, Visser AJ, Marais DC, Stopforth HB, Nyarko JK, Stellmacher GA.
    S Afr Med J; 2001 Aug; 91(8):679-84. PubMed ID: 11584784
    [Abstract] [Full Text] [Related]

  • 16. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
    Faria EF, Carvalhal GF, dos Reis RB, Tobias-Machado M, Vieira RA, Reis LO, Nogueira L, Machado RD, Freitas CH, Magnabosco WJ, Mauad EC, Carvalho AL.
    BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
    [Abstract] [Full Text] [Related]

  • 17. Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.
    Luboldt HJ, Bex A, Swoboda A, Hüsing J, Rübben H, Early Detection Project Group of the German Urological Association.
    Eur Urol; 2001 Feb; 39(2):131-7. PubMed ID: 11223671
    [Abstract] [Full Text] [Related]

  • 18. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].
    Rodríguez Rodríguez R, Mayayo Dehesa T, Galbis Sanjuan F, Jiménez Cidre M, Burgos Revilla FJ, Gómez dos Santos V, García González R.
    Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042
    [Abstract] [Full Text] [Related]

  • 19. Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination.
    Morote J, Raventós CX, Lorente JA, Enbabo G, López M, de Torres I.
    Eur Urol; 1999 Aug; 36(2):111-5. PubMed ID: 10420031
    [Abstract] [Full Text] [Related]

  • 20. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
    Bretton PR, Evans WP, Borden JD, Castellanos RD.
    Cancer; 1994 Dec 01; 74(11):2991-5. PubMed ID: 7525040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.